Differential effect of phototherapy on the activities of human natural killer cells and cytotoxic T cells.
Exposure to ultraviolet B (UV-B) light is recognized to induce suppression of certain immune responses, particularly delayed hypersensitivity. However, its effect on cytotoxic T lymphocyte (CTL) activity, of major importance in the resistance to viruses and tumours, has not been assessed to the same extent. In this study five normal subjects, seropositive for herpes simplex virus (HSV), underwent a standard course of broadband UV-B therapy, as used in the treatment of psoriasis. They received whole-body irradiation thrice weekly for four weeks with incremental doses dependent on skin type. Blood samples were taken immediately before, at two time points during, and at the end of the therapy. An HSV-specific CTL assay was performed using autologous B cells transformed with Epstein-Barr virus as targets. No consistent modulation in CTL activity was obtained as a result of the therapy. The CTLs were separated into CD4 and CD8 subsets by positive selection and, again, no effect of irradiation on CTL activity within each of these two populations was observed. In contrast, the natural killer (NK) cell activity, assessed by the lysis of K562 cells, was significantly reduced at the first time point after the initiation of the phototherapy in all five subjects, and it continued to decline as the treatment progressed. Thus a differential effect of UV-B exposure on cytotoxic activity has been demonstrated: the HSV-specific CTL response is unchanged, while the NK response is suppressed.
Neill
W A
WA
Department of Medical Microbiology, University of Edinburgh Medical School, UK.
Halliday
K E
KE
Norval
M
M
D000328:Adult; D015703:Antigens, CD / Q000528:radiation effects; D005260:Female; D006684:HLA-DR Antigens / Q000528:radiation effects; D006561:Herpes Simplex / Q000276:immunology* / Q000532:radiotherapy*; D006801:Humans; D020014:K562 Cells; D007694:Killer Cells, Natural / Q000276:immunology / Q000528:radiation effects*; D008297:Male; D008875:Middle Aged; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000528:radiation effects*; D014467:Ultraviolet Therapy / Q000379:methods*; D014916:Whole-Body Irradiation / Q000379:methods*
D015703:Antigens, CD; D006684:HLA-DR Antigens